• HOME
  • RESEARCH
    • Biology and dysregulation of IncRNAs
    • Ribosomopathies
    • Epigenetic engineering
    • Engineering cellular immunotherapies
    • Drugging SARS-CoV2 RNA-protein interactions
    • Funding
  • PUBLICATIONS
  • WHO WE ARE
    • Principal Investigator
    • Members
    • Collaborators
    • Alumni
    • Positions Available
    • Lab News
    • Communities
  • MENTORSHIP
  • ENTREPRENEURSHIP
  • CONTACT US
Novina Lab - Engineering Biological Technologies into Therapies

Raqia Therapeutics launched!

7/1/2020

0 Comments

 
Raqia Therapeutics begins operations in the Harvard Pagliuca Life Labs. Raqia is a new company based on technology developed in the Novina lab. Clinical advisors include Ken Anderson and Nikhil Munshi, who will help translate the BAT-CAR technology for patients with multiple myeloma.
0 Comments

Collaboration with Takeda

7/1/2020

0 Comments

 
The Novina Lab began work on two sponsored research agreement with Takeda regarding the platform for detecting RNA-protein interactions. ​
0 Comments

    Novina Lab News

    Archives

    July 2021
    May 2021
    February 2021
    January 2021
    December 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    March 2020
    January 2020
    December 2019
    September 2019
    July 2019
    January 2019
    October 2018
    September 2018
    August 2018
    July 2018
    May 2018
    April 2018
    March 2018
    January 2018

    Categories

    All
    Funding
    Lab Updates

    RSS Feed

 HOME | RESEARCH | PUBLICATIONS | WHO WE ARE | MENTORSHIP | ENTREPRENEURSHIP | SUPPORT US | CONTACT US

©2017 Novina Lab at Dana-Farber Cancer Institute